
09/08/2025
Hi All,
It’s been a while since I posted.
I just discovered this study from May of this year and it blew my mind. I wanted to share because I think this is very important information. I especially felt moved to share after having recently seen a couple of patients who are receiving Librela, despite experiencing neuropathology, neurological signs.
Please, please….ONLY agree to using Librela as a last resort…an absolute last resort. There are plenty of other options for relieving pain and improving mobility before you need to take that route: acupuncture/electroacupuncture, herbal therapy, class IV laser therapy, canine rehab therapy (the legal term for a canine physical therapy), PRP/stem cell therapy, etc.
Of particular note, is this sentence:
“A review of 19 suspected musculoskeletal adverse events (MSAEs) by an 18-member expert panel unanimously concluded a strong suspicion of a causal association between bedinvetmab and accelerated joint destruction.”
18 EXPERTS agreed, UNANIMOUSLY.
It is not often that something like that happens.
The conclusion of the study is as follows :
“Results: The disproportionality analysis did not support the hypotheses. Ligament/tendon injury, polyarthritis, fracture, musculoskeletal neoplasia, and septic arthritis were reported ~9-times more frequently in Librela-treated dogs than the combined total of dogs treated with the comparator drugs. A review of 19 suspected musculoskeletal adverse events (MSAEs) by an 18-member expert panel unanimously concluded a strong suspicion of a causal association between bedinvetmab and accelerated joint destruction.
Conclusion: This study supports recent FDA analyses by demonstrating an increased reporting rate of musculoskeletal adverse events in dogs treated with Librela. Further investigation and close clinical monitoring of treated dogs are warranted.”
ObjectivesTo conduct a specialist-led disproportionality analysis of musculoskeletal adverse event reports (MSAERs) in dogs treated with bedinvetmab (Librela...